Livea vs Oak: Prices, Programs & Reviews (2026)
Side-by-side comparison updated for 2026. ClearScores, pricing, medications, and ratings compared.
Quick Verdict
Livea has the higher ClearScore (73 vs 70)
Livea is more affordable ($69/mo vs $130/mo)
Livea has higher ratings (4.5/5 vs 4/5)
Livea
$69/mo
starting price
Minnesota's Best Gold Award winner 5 years running. Custom nutrition plans + GLP-1 medications from $69/mo.
Oak
$130/mo
starting price
Affordable compounded GLP-1s. Semaglutide from $130/mo, tirzepatide from $199/mo. No membership fees, free shipping, $50 off first month.
Livea vs Oak: Full Comparison
| Livea | Oak | |
|---|---|---|
| ClearScore | 73/100 ✓ | 70/100 |
| Overall Rating | 4.5/5 ✓ | 4/5 |
| Review Count | 93 ✓ | 0 |
| Starting Price | $69/mo ✓ | $130/mo |
| Medications | Semaglutide, Tirzepatide | Compounded Semaglutide, Compounded Tirzepatide |
| Telehealth | Yes | Yes |
| Insurance | Not accepted | Not accepted |
| HSA/FSA | Accepted | Not accepted |
| Founded | 2009 | 2024 |
| States Served | 2 states | All 50 states |
Programs & Pricing
Livea Programs
GLP-1 Plan
From $69/mo
Medications: Semaglutide, Tirzepatide
- Medication Management
- Custom Meal Plan
- One On One Coaching
Livea Complete
From $199
Medications: Semaglutide, Tirzepatide
- Medication Management
- Custom Meal Plan
- Coaching
- Metabolic Assessment
Oak Programs
Compounded Semaglutide
From $130/mo
Medications: Compounded Semaglutide
- Medication
- Doctor Consultation
- Care Team Support
- Free Shipping
Compounded Tirzepatide
From $199/mo
Medications: Compounded Tirzepatide
- Medication
- Doctor Consultation
- Care Team Support
- Free Shipping
Ratings Breakdown
| Category | Livea | Oak |
|---|---|---|
| Overall | | |
| Value | | |
| Ease of Use | | |
| Support | | |
| Medication Quality | | |
| Results | | |
The Bottom Line
Livea edges out Oak with a ClearScore of 73 vs 70. Livea is more affordable starting at $69/mo compared to $130/mo. For customer support, Livea rates higher (4.5/5). The best choice depends on your priorities, medication preferences, and budget.